Expression of OLFM4 (olfactomedin 4), an antiapoptotic factor known to act as a marker for colorectal and gastric cancer [37], [38], was also decreased in athletes, perhaps denoting a potential benefit of exercise training against these tumor types. Here, OLFM4 is linked to neoplasm.